semaglutide mcas attenuates neuroinflammation in male mice FDA Clears Semaglutide For Cardiac

GLP-1s account for 8% of all US prescriptions GLP-1 RA prescribing has reached a new milestone, with nearly 8% of all prescriptions in March 2026 attributed to these therapies following the largest quarter-over-quarter percentage point increase in overall GLP-1 RA prescribing observed since the study began in 2019

Its a weekly injection approved in the UK for type 2 diabetes and, following NICE guidance (TA1026), for weight management

This medicine can interact with certain other treatments, especially blood thinners and blood pressure medications

Ren Z, Liu C, Wei Y, Liu C, Shi C, Wang X, Tang Y, Wang R, Liu Z

This mechanism enhances insulin secretion in response to meals, suppresses glucagon release, and slows gastric emptying

Through Klarity, you can complete this entirely online with same-day appointments